Abstract:Genetic toxicity testing assesses the potential of compounds to cause DNA damage. There are many genetic toxicology screening assays designed to assess the DNA damaging potential of chemicals in early drug development aiding the identification of promising drugs that have low-risk potential for causing genetic damage contributing to cancer risk in humans. Despite this, in vitro tests generate a high number of misleading positives, the consequences of which can lead to unnecessary animal testing and/or the abandonment of promising drug candidates. Understanding chemical Mode of Action (MoA) is vital to identifying the true genotoxic potential of substances and, therefore, the risk translation into the clinic. Here we demonstrate a simple, robust protocol for staining fixed, human-lymphoblast p53 proficient TK6 cells with antibodies against ɣH2AX, p53 and pH3S28 along with DRAQ5TM DNA staining that enables analysis of un-lysed cells via microscopy approaches such as imaging flow cytometry. Here, we used the Cytek® Amnis® ImageStream®X Mk II which provides a high-throughput acquisition platform with the sensitivity of flow cytometry and spatial morphological information associated with microscopy. Using the ImageStream manufacturer's software (IDEAS® 6.2), a masking strategy was developed to automatically detect and quantify micronucleus events (MN) and characterise biomarker populations. The gating strategy developed enables the generation of a template capable of automatically batch processing data files quantifying cell-cycle, MN, ɣH2AX, p53 and pH3 populations simultaneously. In this way, we demonstrate how a multiplex system enables DNA damage assessment alongside MN identification using un-lysed cells on the imaging flow cytometry platform. As a proof-of-concept, we use the tool chemicals carbendazim and methyl methanesulphonate (MMS) to demonstrate the assay's ability to correctly identify clastogenic or aneugenic MoAs using the biomarker profiles established.

Cytokinesis-Block Micronucleus Cytome Assay Evolution into a More Comprehensive Method to Measure Chromosomal Instability

Review of the origin, fate, and influencing factors of cytokinesis-block micronucleus

Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells.

Evaluating Chromosome Instability and Genotoxicity Through Single Cell Quantitative Imaging Microscopy

A survey of chromosomal instability measures across mechanistic models

Micronucleus Formation Detected by Live-Cell Imaging.

micronuclAI: Automated quantification of micronuclei for assessment of chromosomal instability.

A survey of CIN measures across mechanistic models

An Automated, Single Cell Quantitative Imaging Microscopy Approach to Assess Micronucleus Formation, Genotoxicity and Chromosome Instability

Automated detection of cytokinesis-blocked micronuclei using fuzzy c-means algorithm and morphological features

The Micronucleus Assay on Cryopreserved Whole Blood

Micronucleus Assay of Human Lymphocytes: A Comparison of Cytokinesis‐block and Human Capillary Blood Lymphocytes Methods

The molecular origins and pathophysiological consequences of micronuclei: New insights into an age-old problem

Micronucleus Assay: The State of Art, and Future Directions

Image-based identification and isolation of micronucleated cells to dissect cellular consequences

Epigenetic dysregulation from chromosomal transit in micronuclei

A multi-biomarker micronucleus assay using imaging flow cytometry

Tools used to assay genomic instability in cancers and cancer meiomitosis

Inter-laboratory automation of the in vitro micronucleus assay using imaging flow cytometry and deep learning

Micronuclei and Cancer

In Vivo Micronucleus Assay in Mouse Bone Marrow